T1	CHEM 68 79	posaconazol
#1	AnnotatorNotes T1	C0936148; posaconazole; Organic Chemical · Pharmacologic Substance
T2	ANAT 83 89	sangre
#2	AnnotatorNotes T2	C0005767; Blood; Body Substance
T3	CHEM 124 131	fármaco
#3	AnnotatorNotes T3	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T4	DISO 184 192	leucemia
#4	AnnotatorNotes T4	C0023418; leukemia; Neoplastic Process
T5	DISO 212 232	infecciones fúngicas
#5	AnnotatorNotes T5	C0026946; Mycoses; Disease or Syndrome
T6	PROC 255 292	Estudio secuencial de farmacocinética
T7	ANAT 301 311	plasmático
#6	AnnotatorNotes T7	C0032105; Plasma; Body Substance
T8	CHEM 344 355	posaconazol
#7	AnnotatorNotes T8	C0936148; posaconazole; Organic Chemical · Pharmacologic Substance
T9	DISO 465 482	micosis invasoras
#8	AnnotatorNotes T9	C1262313; Invasive Fungal Infections; Disease or Syndrome
T10	DISO 507 536	Infecciones graves por hongos
T11	DISO 563 580	Micosis invasoras
#9	AnnotatorNotes T11	C1262313; Invasive Fungal Infections; Disease or Syndrome
T12	PROC 643 665	profilaxis antifúngica
T13	DISO 686 697	neutropenia
#10	AnnotatorNotes T13	C0027947; Neutropenia; Disease or Syndrome | C0853697; Neutrophil count decreased; Finding
T14	PROC 719 742	quimioterapia intensiva
T15	DISO 748 776	leucemia aguda mieloblástica
T16	ANAT 763 776	mieloblástica
#11	AnnotatorNotes T16	C0229633; myeloblast; Cell
T17	DISO 779 805	síndromes mielodisplásicos
#12	AnnotatorNotes T17	C0026985; Myelodysplasia; Congenital Abnormality | C3463824; MYELODYSPLASTIC SYNDROME; Neoplastic Process
T18	DISO 875 891	micosis invasora
T19	PROC 907 927	trasplante alogénico
#13	AnnotatorNotes T19	C0040739; Transplantation, Homologous; Therapeutic or Preventive Procedure
T20	DISO 938 972	enfermedad injerto contra receptor
T21	DISO 978 1018	alteraciones de función hepática o renal
T22	ANAT 1002 1010	hepática
#14	AnnotatorNotes T22	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T23	ANAT 1013 1018	renal
#15	AnnotatorNotes T23	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T24	PROC 1079 1091	tratamientos
#16	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	CHEM 670 681	posaconazol
#17	AnnotatorNotes T25	C0936148; posaconazole; Organic Chemical · Pharmacologic Substance
T26	ANAT 949 956	injerto
#18	AnnotatorNotes T26	C0332835; Transplanted tissue; Tissue
T27	Date 13 17	2015
T28	Form 140 146	jarabe
#19	AnnotatorNotes T28	C0991550; Syrup Drug Form; Biomedical or Dental Material
T29	Form 157 165	tabletas
#20	AnnotatorNotes T29	C0039225; Tablet Dosage Form; Functional Concept
T30	LIVB 170 179	pacientes
#21	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	Spec_cue 202 211	riesgo de
T32	PHYS 277 292	farmacocinética
#22	AnnotatorNotes T32	C0031327; Drug Kinetics; Physiologic Function
T33	Route 334 340	orales
#23	AnnotatorNotes T33	C1527415; Oral Route of Drug administration; Functional Concept
T34	Form 357 367	suspensión
#24	AnnotatorNotes T34	C4724031; Suspension Dosage Form; Biomedical or Dental Material
T35	Route 368 372	oral
#25	AnnotatorNotes T35	C1527415; Oral Route of Drug administration; Functional Concept
T36	Form 375 405	comprimidos gastrorresistentes
#26	AnnotatorNotes T36	C0039226; Gastro-resistant oral tablet; Biomedical or Dental Material
T37	LIVB 410 433	pacientes hematológicos
#27	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	Spec_cue 438 444	riesgo
T39	LIVB 530 536	hongos
#28	AnnotatorNotes T39	C0016832; Fungi; Fungus
T40	LIVB 607 624	Pacientes adultos
#29	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T42	Neg_cue 833 844	Se excluyen
T43	LIVB 845 854	pacientes
#30	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T46	LIVB 224 232	fúngicas
#31	AnnotatorNotes T46	C0016832; Fungi; Fungus
T47	LIVB 1047 1058	embarazadas
#32	AnnotatorNotes T47	C0033011; Pregnant Women; Population Group
T41	LIVB 964 972	receptor
#33	AnnotatorNotes T41	C0376387; Transplant Recipients; Patient or Disabled Group
A1	Assertion T43 Negated
A2	Assertion T18 Negated
A3	Assertion T19 Negated
A4	Assertion T21 Negated
A5	Assertion T47 Negated
A6	Assertion T24 Negated
A7	Assertion T5 Speculated
A8	Assertion T9 Speculated
A9	Population_data T40 Age
A10	Status T18 History_of
A11	Status T19 History_of
A12	Status T24 History_of
#34	AnnotatorNotes T12	C0877136; Administration of prophylactic antifungal; Therapeutic or Preventive Procedure 
#35	AnnotatorNotes T15	C0023467; Leukemia, Myelocytic, Acute; Neoplastic Process 
#36	AnnotatorNotes T18	C1262313; Invasive Fungal Infections; Disease or Syndrome
#37	AnnotatorNotes T21	C0085605; Liver Failure; Disease or Syndrome | C1306571; Hepatic Insufficiency; Pathologic Function
#38	AnnotatorNotes T20	C0018133; Graft-vs-Host Disease; Disease or Syndrome
R1	Negation Arg1:T42 Arg2:T43	
R2	Negation Arg1:T42 Arg2:T18	
R3	Negation Arg1:T42 Arg2:T19	
A13	Assertion T20 Negated
R4	Negation Arg1:T42 Arg2:T20	
R5	Negation Arg1:T42 Arg2:T21	
R6	Negation Arg1:T42 Arg2:T47	
R7	Negation Arg1:T42 Arg2:T24	
T44	Quantifier_or_Qualifier 1102 1115	concomitantes
A14	Assertion T44 Negated
#39	AnnotatorNotes T44	C0521115; Simultaneous; Temporal Concept
R8	Negation Arg1:T42 Arg2:T44	
R9	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T44	
T45	DISO 1020 1032	QTc alargado
A15	Assertion T45 Negated
#40	AnnotatorNotes T45	C1560305; Prolonged QTc interval; Pathologic Function
T48	CONC 1038 1042	ECOG
A16	Assertion T48 Negated
#41	AnnotatorNotes T48	C1520224; ECOG performance status; Intellectual Product
R10	Negation Arg1:T42 Arg2:T48	
T49	Result_or_Value 1043 1045	>2
A17	Assertion T49 Negated
R11	Negation Arg1:T42 Arg2:T49	
T50	PROC 57 79	niveles de posaconazol
#42	AnnotatorNotes T50	C5225195; posaconazole level; Laboratory Procedure 
R12	Location_of Arg1:T2 Arg2:T50	
R13	Has_Drug_Form Arg1:T3 Arg2:T28	
R14	Before Arg1:T3 Arg2:T50	
R15	Has_Drug_Form Arg1:T3 Arg2:T29	
R16	Experiences Arg1:T30 Arg2:T50	
R17	Experiences Arg1:T30 Arg2:T4	
R18	Experiences Arg1:T30 Arg2:T3	
R20	Speculation Arg1:T31 Arg2:T5	
R21	Causes Arg1:T46 Arg2:T5	
T51	Observation 197 211	alto riesgo de
#43	AnnotatorNotes T51	C0332167; High risk of; Finding
R22	Before Arg1:T51 Arg2:T5	
R19	Overlap Arg1:T4 Arg2:T51	
T52	Observation 438 455	riesgo elevado de
#44	AnnotatorNotes T52	C0332167; High risk of; Finding
R23	Before Arg1:T52 Arg2:T9	
R24	Speculation Arg1:T38 Arg2:T9	
R25	Location_of Arg1:T7 Arg2:T6	
R27	Experiences Arg1:T30 Arg2:T51	
R28	Has_Route_or_Mode Arg1:T8 Arg2:T33	
R30	Has_Drug_Form Arg1:T8 Arg2:T34	
R31	Has_Route_or_Mode Arg1:T8 Arg2:T35	
R32	Has_Drug_Form Arg1:T8 Arg2:T36	
R33	Experiences Arg1:T37 Arg2:T6	
R34	Experiences Arg1:T37 Arg2:T8	
R35	Experiences Arg1:T37 Arg2:T52	
R36	Experiences Arg1:T37 Arg2:T32	
R37	Causes Arg1:T39 Arg2:T10	
#45	AnnotatorNotes T10	C0026946; Mycoses; Disease or Syndrome (?)
R38	Used_for Arg1:T25 Arg2:T12	
R39	Experiences Arg1:T40 Arg2:T12	
R40	Experiences Arg1:T40 Arg2:T14	
R41	Causes Arg1:T14 Arg2:T13	
T53	Quantifier_or_Qualifier 698 703	grave
#46	AnnotatorNotes T53	C1547227; Severe - Severity of Illness Code; Intellectual Product
R42	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T53	
R43	Experiences Arg1:T40 Arg2:T15	
R44	Location_of Arg1:T16 Arg2:T15	
R45	Experiences Arg1:T40 Arg2:T17	
R46	Before Arg1:T17 Arg2:T13	
R47	Before Arg1:T15 Arg2:T13	
T54	Quantifier_or_Qualifier 704 714	prolongada
#47	AnnotatorNotes T54	C0439590; Prolonged; Temporal Concept
R48	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T54	
R49	Experiences Arg1:T41 Arg2:T20	
R50	Experiences Arg1:T43 Arg2:T18	
R51	Experiences Arg1:T43 Arg2:T19	
R52	Experiences Arg1:T43 Arg2:T20	
R53	Experiences Arg1:T43 Arg2:T21	
R54	Location_of Arg1:T22 Arg2:T21	
R55	Location_of Arg1:T23 Arg2:T21	
R56	Experiences Arg1:T43 Arg2:T45	
R57	Has_Result_or_Value Arg1:T48 Arg2:T49	
R58	Experiences Arg1:T43 Arg2:T24	
R59	Experiences Arg1:T30 Arg2:T5	
R60	Experiences Arg1:T37 Arg2:T9	
A18	Experiencer T30 Patient
A19	Experiencer T37 Patient
A20	Experiencer T40 Patient
A21	Experiencer T43 Patient
A22	Experiencer T41 Patient
A23	Experiencer T47 Patient
